Consolidated Statements of Operations - USD ($)
|
12 Months Ended |
Mar. 31, 2022 |
Mar. 31, 2021 |
| Net revenues |
$ 3,206,594
|
$ 3,090,631
|
| Cost of sales |
1,957,956
|
1,928,789
|
| Gross Profit |
1,248,638
|
1,161,842
|
| Operating expenses: |
|
|
| Research and development |
615,926
|
655,962
|
| Selling, general and administrative |
1,673,690
|
1,049,198
|
| Stock based compensation |
0
|
17,603
|
| Depreciation and amortization |
88,336
|
119,557
|
| Total operating expenses |
2,377,952
|
1,842,320
|
| Loss from operations |
(1,129,314)
|
(680,478)
|
| Other income (expense): |
|
|
| EIDL Grant |
0
|
10,000
|
| Forgiveness of Paycheck Protection Program loan |
693,817
|
0
|
| Interest income |
3,013
|
14,588
|
| Interest and finance expenses |
15,597
|
10,386
|
| Total other income |
681,233
|
14,202
|
| Loss before provision for taxes |
(448,081)
|
(666,276)
|
| Provision (benefit) for income taxes: |
|
|
| Current |
(19,818)
|
(6,000)
|
| Deferred |
956,000
|
(62,000)
|
| Total benefit (provision) for income taxes |
936,182
|
(68,000)
|
| Net loss |
$ (1,384,263)
|
$ (598,276)
|
| Basic and diluted loss per common share: (in dollars per share) |
$ (0.02)
|
$ (0.01)
|
| Weighted average shares of common stock outstanding - basic and diluted (in shares) |
67,588,492
|
67,588,492
|